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Malignant Melanoma
Angie Whitt, RN
Otterbein University, Westerville, Ohio
Presentation of
Case/Introduction
Summer is here and it is an important time
of year to teach about prevention and
detection of skin cancer. Many people
expose his/her skin (or a child’s skin) to
harmful ultraviolet light produced by the
sun without knowing the risk that are
involved. Malignant melanoma or
cutaneous melanoma is the most deadly
type of skin cancer and “the number of
people that have acquired melanoma has
nearly doubled since 1973. Although
melanoma only accounts for approximately
1% of skin cancer diagnoses, it accounts for
70 - 75% of skin cancer related deaths
(Deepanwitta & Tackett, 2016. para 2).”
Melanoma is also a highly invasive cancer.
Early detection is key to positive prognosis
(late stage melanoma is usually not curable
because it is invasive and metastasizes). As
an advanced practice nurse, it is important
to recognize and assess for melanoma,
even if this is not the patients primary
complaint, since early detection could be
life-saving.
“There are many types of melanoma but
the four most common types of melanoma
include:
~ Superficial spreading melanoma accounts
for 70% of all diagnosed melanomas. It
occurs most often in the younger
populations. This type of melanoma begins
to grow along the top of the skin (in situ)
and with time, will metastasize. Various
colors (white, black, red, blue, brown, or
tan) and irregular borders are typical for
this melanoma.
~ Lentigo maligna usually occurs in the
elderly population on skin that has been
chronically exposed to direct sun light. It
appears tan, brown, or dark brown in color.
It is also a superficial type of melanoma
that slowly becomes invasive.
~ Acral lentiginous melanoma is usually a
black or brown pigmentation that grows
under the nails or on the palms/soles of
hands /feet. It is the most frequent
melanoma in Asians and African-Americans,
but is less frequently occurring in the
Caucasian populations.
~ Nodular melanoma is visualized as a darkcolored lump on your skin. This type of
melanoma is highly invasive and grows into
the skin unlike the other types of
melanomas that grow across the top of the
skin. It may be black, blue, red, white, grey,
brown, or tan. This type of melanoma
makes up approximately 10%-15% of
diagnosed melanomas.
(“Skin Cancer Foundation,” 2018)
(Pullen, Whitehead, & Pastwa, 2011)

Underlying
Pathophysiology
Malignant Melanoma is a type of skin
cancer that stems from melanocytes.
These are the pigment producing cells
that gives the skin its color. Mutated
melanocytes grow to be malignant
melanoma (Castellania et al., 2017).
Although the exact cause of melanoma is
unclear, an increased exposure to
ultraviolet radiation has been linked to
obtaining this type of cancer. It is
possible that a genetic link may also be
involved in some cases of melanoma.
Factors that increase a person’s risk of
contracting melanoma include:
~ A family history of melanoma.
~ A history of one or more severe sun
burns (especially blistering sun buns).
~ An excessive exposure to ultraviolet
light (such as tanning beds or having a
job that requires one to work out in the
sun every day).
~ Having multiple moles or moles of
irregular shapes or sizes (atypical
moles).
~ Having fair or lighter pigmented skin,
blue or green eyes, or those with blond
or red hair.
~ Living at higher elevations or closer to
the equator where there is more
ultraviolet radiation and the light is more
direct.
~ Having a suppressed immune system
(including those with the HIV virus or
AIDS, who have received an organ
transplant, or who are receiving
immunotherapy,
(“Mayo Clinic,” 2016, para 20)

Significance of
Pathophysiology
Melanoma accounts for approximately
5% of skin cancers and is the most fatal
type. It is the fastest growing of all
malignancies in men and the second
fastest growing malignancy in women
(Castellania et al., 2017). Due to the high
mortality rate of Melanoma, there has
been an increase in interest and scientific
studies in recent years. (Basi HR,
Alicezaei, Ahovan, & Moradi, 2017).
“Advanced melanoma is highly invasive
and metastasizes quickly to the lymph
nodes, lungs, liver, and brain (“We Are
MacMillan. Cancer Support,”2018,
para.1).”
One study performed, “Does Proximity of
the Primary Tumour to the Lymph Node
Basin, in Patients with Malignant
Melanoma, Influence the Chance of
Sentinel Node Positivity?,” showed a link
between the proximity of a melanoma
lesion to the lymph nodes and the
increase chance of lymph node
metastasis (Hunt et al, 2017). With this
information in mind, it is especially
important to assess moles and skin
discolorations that are in hard-to-see (or
often covered by clothes) places proximal
to the trunk of the body.
Doctors usually do not deem a patient
cured once a melanoma has been
removed because of the risk that it may
return in the years following. Instead,
doctors use time increments of five years
to assess survival rates. Studies have
shown that the earlier the stage of
melanoma when a patient receives the
diagnosis, the longer the survival rate.
(“Bupa,”2018)

Signs & Symptoms
Melanoma usually presents in areas most often exposed to the sun, but may present
anywhere on the body. “Thinking of "ABCDE" can help you remember what to look for.
Assess moles or other pigmentations on the skin for:
~Asymmetry: The shape of one half does not match the other half.
~ Border that is irregular: The edges are often ragged, notched, or blurred in outline. The
pigment may spread into the surrounding skin.
~ Color that is uneven: Shades of black, brown, and tan may be present. Areas of white,
gray, red, pink, or blue may also be seen.
~ Diameter: There is a change in size, usually an increase. Melanomas can be tiny, but most
are larger than the size of a pea (larger than 6 millimeters or about 1/4 inch).
~ Evolving: The mole has changed over the past few weeks or months”
(“National Cancer Institute,” 2011, para 1)
Hidden melanomas may be found in
unexpected areas of the body such as
under the nail beds of the fingers and
toes, palms of hands and feet, mucous
membranes and body openings, or
within the eye (“Mayo Clinic,” 2016).
“Although changes in a mole or
pigmentation on an area of one’s skin
my be an early symptom of melanoma,
late symptoms (or symptoms that the
melanoma has metastasized) include:
~ Lymph nodes – may feel hard and
swollen
~ Skin – hard lumps may appear
~ Lungs – one may be breathless or have
a cough that doesn’t get better
~ Liver – one may feel pain in the upper
right side of the abdomen
~ Bones – one may have an ache in
his/her bones
~ Brain – a headache that doesn’t go
away.”
(“We Are MacMillan. Cancer Support,”
2018, para. 1)
Image courtesy of Mayo Clinic

Implications for Nursing Care

Image courtesy of Bupa

A thorough, yearly skin assessment for all patients, but especially those with a history of
melanoma or at high risk of obtaining melanoma, is imperative to catch melanoma in its
earliest stages. Inquire about any ulcerated or open areas of skin, areas that itch or burn,
or any irregular pigmentations of the skin. Obtaining the patients family history of
melanoma and history of ultraviolet light exposure is vital as well.
Nursing care is dependent upon the staging of the melanoma. Staging of a melanoma is a
way to categorize the severity of the disease. Staging identifies the depth of penetration
that is involved with the melanoma and if any metastasis involved. Stage 0 tumors are in
situ, stage1 are localized to the epidermis and dermis, stage 2 are usually over 1mm thick
and may have ulceration or risk of spreading to nearby lymph nodes, stage 3 is localized
metastasis and lymph node involvement, stage 4 is metastasis to other areas of the body,
stage 5 is brain metastasis (“Skin Cancer Foundation,” 2018).
In early stages of melanoma, nursing care involves wound care and healing of the area of
skin that has been excised as well as measures to prevent the return of future melanomas.
Nursing care for later stages of melanoma may include wound care as well as managing
treatments specific for the type and depth of melanoma involved.
(Pullen, Whitehead, & Pastwa, 2011)

Treatments

Conclusions
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Early stages of melanoma are best treated
by surgical removal of the malignant areas
of skin. If one is unable to undergo
surgical removal of the melanoma,
therapies such as radiotherapy, scraping
or freezing off the melanoma, or
treatment with a cream called imiquimod
(“Bupa,” 2018, para.21) have shown
effectiveness in removal of the melanoma.
Radiotherapy, Immunotherapy,
Chemotherapy, and targeted therapies are
used to treat advanced melanomas
(“Bupa,”2018). Late stages of melanoma
are more difficult to treat, resistant to
apoptosis, and often deadly due to
resistance to chemotherapy drugs or other
treatments (Cox, 2015).
Specific treatments for advanced
melanoma are as follows:
~ Twenty different genes are linked to
inhibiting malignant metastasis. Studies
involving metastasis inhibitors are being
performed, but not yet available for
clinical use. Metastasis is inhibited and
apoptosis is encouraged in melanoma cells
by a cysteine protease inhibitor called
Cystatin C .
~ Apoptosis of melanoma cells are also
encouraged by prompting the MAPK and
PI3K signaling pathway, which are two
pathways that melanoma cells proliferate.
~ The chemotherapy agent Dacerbazine
has show to provide some effectiveness to
prevent melanoma DNA replication.
~ Vemurafenib, also a chemotherapeutic
agent and BRAF V600E antagonist, is
effective in treating BRAF V600E mutant
melanoma, but a resistance to this drug is
often quickly acquired.
~ A Biologic response modifier, IL-2, has
also produced long term remission for
some melanoma patients, but have side
effects such as nausea, vomiting, and
fatigue
~ Immunotherapy has been shown
successful in a small percentage of
patients using check point inhibitors, such
as Ipilimumab,
~ Therapeutic, cell-killing viruses (such as
T-vec) are being tested and have proven to
have dual benefits by eradicating
melanoma cells and encouraging a
patient’s immune response to the cancer
cells.
~ Since melanoma is a type of angiogenic
cancer, Angiogenesis inhibitors such as
bevicezuma, are being tested in clinical
trials and used as an adjunct to
chemotherapy.
(Cox, 2015).

The most frequently occurring
malignancy in the United States is skin
cancer (when taking into account all
types of skin cancer). Skin cancer occurs
more often than colon, breast, prostate,
and lung cancers combined. 1/5
Americans will have some form of skin
cancer at some point in his or her
lifetime. It is important for a health care
professional to distinguish melanoma
from other types of skin cancer due to it
invasiveness.
Prevention from acquiring melanoma is
the first line of defense. Ways a person
can avoid melanoma include:
~ Avoiding direct sunlight, (stay in the
shade) between 11am and 3pm when
ultraviolet rays are strongest.
~ Wearing clothing such as hats,
sunglasses, and long sleeves to cover
sun-exposed skin.
~ Cover any sun-exposed skin with a high
sun protection factor (SPF) sun screen of
at least 30 or higher. (Pullen, Whitehead,
& Pastwa, 2011)
Melanoma begins as a small change in an
area of the skin and is very treatable if
detected early.
Early detection and removal of
melanoma are the second line of
defense. Scraping, freezing or surgical
removal at the earliest opportunity is
crucial to prevent the melanoma from
growing thicker, wider, or metastasizing.
In biopsies of melanoma of the skin,
studies have shown that an increase in
mitotic activity correlates with an
increase in depth of the malignant cells.
An increase in mitotic activity could also
mean an increase in tumor growth and
metastasis. This information is useful to
determine the appropriate treatment
and depth of excision of the malignancy
(Basi HR, Alicezaei, Ahovan, & Moradi,
2017).
After removal of the melanoma,
radiotherapy, immunotherapy,
chemotherapy, and targeted therapies
used to treat advanced melanomas and
are specific to the type and distance of
metastasis of the melanomas. It is
important for studies (such as
angiogenesis inhibitors and proteomics)
to continue to lower the mortality rate of
melanoma (Deepanwitta & Tackett,
2016).
Those with a history of any type of
melanoma will always be at risk of reemerging melanomas and should
continue with yearly head-to-toe skin
examinations by a Dermatologist.
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